Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 5,288,000 | 5,074,000 | 4,875,000 | 4,803,000 | 4,436,000 |
| Cost of Goods | 1,220,000 | 1,145,000 | 1,017,000 | 1,175,000 | 1,142,000 |
| Gross Profit | 4,068,000 | 3,929,000 | 3,858,000 | 3,628,000 | 3,294,000 |
| Operating Expenses | 3,086,000 | 2,891,000 | 3,077,000 | 2,597,000 | 2,452,000 |
| Operating Income | 982,000 | 1,038,000 | 781,000 | 1,031,000 | 842,000 |
| Other Income | 157,000 | 70,000 | 88,000 | 88,000 | 79,000 |
| Pre-tax Income | 1,139,000 | 1,108,000 | 869,000 | 1,119,000 | 921,000 |
| Income Tax | 301,000 | 305,000 | 226,000 | 308,000 | 253,000 |
| Net Income Continuous | 833,000 | 801,000 | 635,000 | 803,000 | 666,000 |
| Net Income | $833,000 | $801,000 | $635,000 | $803,000 | $666,000 |
| EPS Basic Total Ops | 0.25 | 0.24 | 0.19 | 0.24 | 0.20 |
| EPS Basic Continuous Ops | 0.25 | 0.24 | 0.19 | 0.24 | 0.20 |
| EPS Diluted Total Ops | 0.25 | 0.24 | 0.19 | 0.24 | 0.20 |
| EPS Diluted Continuous Ops | 0.25 | 0.24 | 0.19 | 0.24 | 0.20 |
| EBITDA(a) | $672,000 | $1,348,000 | $-119,000 | $1,373,000 | $1,128,000 |